[1] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版). 中华肝脏病杂志, 2020,2:112-127. [2] 刘 会永, 万象新, 陈先平, 等. CT动态增强与MRI诊断小肝癌的效果对比分析. 肝脏, 2019,3:326-328. [3] Lee S, Kim MJ, Kim SS, et al. Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging. Hepatol Int, 2020,14:70-79. [4] Choi SH, Lee SS, Park SH, et al. LI-RADS Classification and Prognosis of Primary Liver Cancers at Gadoxetic Acid-enhanced MRI. Radiology, 2019,290:388-397. [5] Kang JH, Choi SH, Byun JH, et al. Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepato cellular carcinoma ≤3 cm on magnetic resonance imaging. Eur Radiol, 2020,30:2881-2889. [6] Byun J, Choi SH, Byun JH, et al. Comparison of the diagnostic performance of imaging criteria for HCCs≤3.0 cm on gadoxetate disodium-enhanced MRI. Hepatol Int, 2020,14:534-543. [7] Darnell A, Forner A, Rimola J, et al. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detec ted in Cirrhosis at Screening US. Radiology, 2015,275:698-707. [8] Tang Q, Ma C. Performance of Gd-EOB-DTPA-enhanced MRI for the diagnosis of LI-RADS 4 category hepatocellular carcinoma nodules with different diameters. Oncol Lett, 2018,16:2725-2731. [9] Basha MAA, Refaat R, Mohammad FF, et al. The utility of diffusion-weighted imaging in improving the sensitivity of LI-RADS classification of s mall hepatic observations suspected of malignancy. Abdom Radiol (NY), 2019,44:1773-1784. [10] De Gaetano AM, Catalano M, Pompili M, et al. Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magneti c resonance imaging. Eur Rev Med Pharmacol Sci, 2019,23:7786-7801. [11] Ronot M, Fouque O, Esvan M, et al. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm. J Hepatol, 2018,68:715-723. [12] Min JH, Kim JM, Kim YK, et al. Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System. Hepatology, 2018,68:2254-2266. [13] 杜婧, 杨大为, 张楠, 等. 基于肝脏影像报告和数据系统肝细胞肝癌MRI征象判读的一致性. 中国医学影像学杂志, 2019,27:481-486. [14] 王影, 余深平, 刘影, 等. 根据2013版肝脏影像报告与数据管理系统诊断肝脏病灶的一致性. 中国介入影像与治疗学, 2020,17:172-176. [15] 杨采薇, 蒋涵羽, 宋彬, 等. 基于钆塞酸二钠增强MRI采用2018版LI-RADS诊断肝细胞癌的效能. 中华放射学杂志, 2019,53:1060-1064. |